Literature DB >> 19207372

Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged men.

L Jartti1, T Rönnemaa, O T Raitakari, E Hedlund, N Hammar, R Lassila, J Marniemi, M Koskenvuo, J Kaprio.   

Abstract

BACKGROUND: Study of migrants offers a natural model to assess environmental risk of coronary heart disease (CHD) in countries differing in CHD occurrence. In Sweden, CHD risk has been markedly lower than in Finland from where a large migration occurred in the 1970s.
OBJECTIVES: To study the structural and functional markers of subclinical atherosclerosis in twin pairs discordant for migration with the main focus on age at migration, length of residence and integration into Swedish society after migration from a high to a lower CHD risk country.
METHODS: Carotid intima-media thickness (IMT) and brachial artery endothelial function (EF) were assessed with high-resolution ultrasound and a set of cardiovascular, socio-economic and psychosocial risk factors were estimated in 76 middle-aged male twin pairs discordant for migration from Finland to Sweden.
RESULTS: Men who had migrated in adolescence had lower IMT values compared with their co-twins living in Finland (0.665 +/- 0.114 vs. 0.802 +/- 0.167 mm, P = 0.009). Also men who integrated well to Swedish society had lower (0.720 +/- 0.154 vs. 0.799 +/- 0.207 mm, P = 0.013) IMT values than their twin brothers living in Finland. Associations between IMT and migration age and between IMT and integration remained significant in multivariate analyses of several CHD risk factors. The intrapair difference in IMT was significantly associated with immigration age and integration (ANOVA, P = 0.0082), the difference being greatest among pairs where the brother living in Sweden had migrated at early age and integrated well to Swedish society. EF was better in men who had migrated to Sweden before the age of 21 years, but not later, compared with their co-twins in Finland (6.4 +/- 4.6% vs. 3.8 +/- 3.6%, P = 0.025).
CONCLUSIONS: Migration at an early age and good integration are beneficial to vascular health associated with moving from a high to a lower CHD risk country, suggesting that an environment-sensitive period influences atherogenesis before adulthood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19207372     DOI: 10.1111/j.1365-2796.2008.02018.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  4 in total

1.  Higher usual alcohol consumption was associated with a lower 41-y mortality risk from coronary artery disease in men independent of genetic and common environmental factors: the prospective NHLBI Twin Study.

Authors:  Jun Dai; Kenneth J Mukamal; Ruth E Krasnow; Gary E Swan; Terry Reed
Journal:  Am J Clin Nutr       Date:  2015-05-06       Impact factor: 7.045

2.  Intake of food rich in saturated fat in relation to subclinical atherosclerosis and potential modulating effects from single genetic variants.

Authors:  Federica Laguzzi; Buamina Maitusong; Rona J Strawbridge; Damiano Baldassarre; Fabrizio Veglia; Steve E Humphries; Rainer Rauramaa; Sudhir Kurl; Andries J Smit; Philippe Giral; Angela Silveira; Elena Tremoli; Anders Hamsten; Ulf de Faire; Bruna Gigante; Karin Leander
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

3.  Work and health among immigrants and native Swedes 1990-2008: a register-based study on hospitalization for common potentially work-related disorders, disability pension and mortality.

Authors:  Bo Johansson; Magnus Helgesson; Ingvar Lundberg; Tobias Nordquist; Ola Leijon; Per Lindberg; Eva Vingård
Journal:  BMC Public Health       Date:  2012-10-05       Impact factor: 3.295

4.  The association between postload plasma glucose levels and 38-year mortality risk of coronary heart disease: the prospective NHLBI Twin Study.

Authors:  Jun Dai; Ruth E Krasnow; Lei Liu; Stephen G Sawada; Terry Reed
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.